As of 2025-03-16, the Relative Valuation of Seres Therapeutics Inc (MCRB) is (5.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.69 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is -918.7%.
The range of the Relative Valuation is (4.67) - (7.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.3x - 47.9x | 41.2x |
| Forward P/E multiples | 26.9x - 48.6x | 34.5x |
| Fair Price | (4.67) - (7.15) | (5.65) |
| Upside | -777.5% - -1136.5% | -918.7% |
| Date | P/E |
| 2025-03-06 | -4.92 |
| 2025-03-05 | -5.13 |
| 2025-03-04 | -4.49 |
| 2025-03-03 | -5.02 |
| 2025-02-28 | -5.09 |
| 2025-02-27 | -4.86 |
| 2025-02-26 | -5.03 |
| 2025-02-25 | -5.21 |
| 2025-02-24 | -5.29 |
| 2025-02-21 | -5.39 |
| 2025-02-20 | -5.44 |
| 2025-02-19 | -5.56 |
| 2025-02-18 | -5.57 |
| 2025-02-14 | -5.58 |
| 2025-02-13 | -5.63 |
| 2025-02-12 | -5.48 |
| 2025-02-11 | -5.36 |
| 2025-02-10 | -5.26 |
| 2025-02-07 | -5.24 |
| 2025-02-06 | -5.23 |
| 2025-02-05 | -5.30 |
| 2025-02-04 | -5.40 |
| 2025-02-03 | -5.57 |
| 2025-01-31 | -5.66 |
| 2025-01-30 | -5.74 |
| 2025-01-29 | -5.40 |
| 2025-01-28 | -5.45 |
| 2025-01-27 | -5.64 |
| 2025-01-24 | -5.78 |
| 2025-01-23 | -5.95 |
| 2025-01-22 | -6.11 |
| 2025-01-21 | -4.90 |
| 2025-01-17 | -5.14 |
| 2025-01-16 | -4.93 |
| 2025-01-15 | -5.23 |
| 2025-01-14 | -5.14 |
| 2025-01-13 | -5.52 |
| 2025-01-10 | -5.66 |
| 2025-01-08 | -5.70 |
| 2025-01-07 | -5.83 |
| 2025-01-06 | -6.08 |
| 2025-01-03 | -6.07 |
| 2025-01-02 | -5.65 |
| 2024-12-31 | -5.57 |
| 2024-12-30 | -5.57 |
| 2024-12-27 | -5.94 |
| 2024-12-26 | -6.19 |
| 2024-12-24 | -6.43 |
| 2024-12-23 | -6.47 |
| 2024-12-20 | -6.14 |